JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.28% |
| 2 | Technology | 17.17% |
| 3 | Healthcare | 10.79% |
| 4 | Financials | 9.36% |
| 5 | Consumer Discretionary | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4526
Invesco Municipal Opportunity Trust
VMO
$569M
| $335K | ﹤0.01% |
+34,190
| New | +$332K |
2023 Q1
0 quarters
|
|
4527
Gilat Satellite Networks
GILT
$710M
| $335K | ﹤0.01% |
65,396
+15,140
| +30% | +$86K |
2019 Q3
14 quarters
|
|
|
STER
4528
DELISTED
Sterling Check Corp. Common Stock
STER
| $335K | ﹤0.01% |
30,058
+5,292
| +21% | +$69.6K |
2021 Q3
6 quarters
|
|
4529
CALL
Shift4
FOUR
$3.04B
| $334K | ﹤0.01% |
4,400
+3,200
| +267% | +$206K |
2022 Q4
1 quarter
|
|
|
SRDX
4530
DELISTED
Surmodics
SRDX
| $333K | ﹤0.01% |
14,633
+1,510
| +12% | +$38.9K |
2013 Q2
39 quarters
|
|
4531
Sutro Biopharma
STRO
$240M
| $332K | ﹤0.01% |
7,167
-11,611
| -62% | -$737K |
2018 Q3
18 quarters
|
|
4532
Archer Aviation
ACHR
$3.58B
| $331K | ﹤0.01% |
115,662
+28,247
| +32% | +$76.2K |
2022 Q2
3 quarters
|
|
4533
Ramaco Resources Class A
METC
$523M
| $331K | ﹤0.01% |
38,971
+13,867
| +55% | +$130K |
2017 Q4
21 quarters
|
|
4534
Invesco Global Clean Energy ETF
PBD
$117M
| $329K | ﹤0.01% |
16,653
| – | – |
2020 Q4
9 quarters
|
|
4535
CALL
Boston Beer
SAM
$1.75B
| $329K | ﹤0.01% |
+1,000
| New | +$344K |
2023 Q1
0 quarters
|
|
4536
CALL
Nutanix
NTNX
$19.9B
| $327K | ﹤0.01% |
12,600
-7,100
| -36% | -$192K |
2022 Q4
1 quarter
|
|
4537
Exchange Listed Funds Trust ETC Cabana Target Drawdown 10 ETF
TDSC
$104M
| $327K | ﹤0.01% |
+14,831
| New | +$330K |
2023 Q1
0 quarters
|
|
4538
PUT
Ulta Beauty
ULTA
$23.4B
| $327K | ﹤0.01% |
600
-2,000
| -77% | -$1.03M |
2022 Q4
1 quarter
|
|
|
DBD
4539
DELISTED
Diebold Nixdorf Incorporated
DBD
| $327K | ﹤0.01% |
272,308
+118,905
| +78% | +$265K |
2013 Q2
39 quarters
|
|
|
DIAX
4540
DELISTED
Nuveen Dow 30SM Dynamic Overwrite Fund
DIAX
| $326K | ﹤0.01% |
22,218
+17,899
| +414% | +$272K |
2022 Q4
1 quarter
|
|
|
EVAV
4541
DELISTED
Direxion Daily Electric and Autonomous Vehicles Bull 2X Shares
EVAV
| $325K | ﹤0.01% |
5,000
| – | – |
2022 Q3
2 quarters
|
|
4542
CALL
Invitation Homes
INVH
$15.6B
| $325K | ﹤0.01% |
+10,400
| New | +$326K |
2023 Q1
0 quarters
|
|
4543
Vanguard Russell 2000 Value ETF
VTWV
$1.32B
| $325K | ﹤0.01% |
2,692
+423
| +19% | +$53.8K |
2020 Q2
11 quarters
|
|
4544
LHA Market State Tactical Beta ETF
MSTB
$202M
| $324K | ﹤0.01% |
+12,495
| New | +$319K |
2023 Q1
0 quarters
|
|
|
TWO
4545
CALL
DELISTED
Two Harbors Investment
TWO
| $324K | ﹤0.01% |
+22,000
| New | +$358K |
2023 Q1
0 quarters
|
|
4546
First Community Bankshares
FCBC
$904M
| $323K | ﹤0.01% |
12,907
+638
| +5% | +$19.6K |
2013 Q2
39 quarters
|
|
4547
Goldman Sachs BDC
GSBD
$1.02B
| $322K | ﹤0.01% |
23,671
+10,844
| +85% | +$162K |
2017 Q1
24 quarters
|
|
|
BTAI
4548
DELISTED
BioXcel Therapeutics
BTAI
| $322K | ﹤0.01% |
1,081
+356
| +49% | +$152K |
2019 Q2
15 quarters
|
|
4549
Altimmune
ALT
$519M
| $321K | ﹤0.01% |
76,085
-103,013
| -58% | -$1.22M |
2020 Q4
9 quarters
|
|
|
AVDL
4550
CALL
DELISTED
Avadel Pharmaceuticals
AVDL
| $321K | ﹤0.01% |
35,000
-4,700
| -12% | -$38.6K |
2022 Q3
2 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 751 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 751 new positions and closed 652 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.